Loading Complete
Nicole M. Salazar-Austin

Nicole M. Salazar-Austin, MD, SCM

Pediatric Infectious Diseases

Accepting New Patients
Online Booking
Johns Hopkins Affiliations:
  • Johns Hopkins School of Medicine Faculty

Languages

  • Spanish
  • English

14 Insurances Accepted

View all

Gender

Female

About Nicole M. Salazar-Austin

Primary Academic Title

Assistant Professor of Pediatrics

Background

Dr. Salazar-Austin completed her undergraduate degree in Biology at the Massachusetts Institute of Technology and her medical degree from Harvard Medical School. She completed pediatrics residency at the Children’s Hospital of Philadelphia. She spent two years as a global health corps physician with the Baylor International Pediatric AIDS Initiative in eSwatini before completing her fellowship in Pediatric Infectious Diseases at the Johns Hopkins University School of Medicine. She completed a Master’s degree in epidemiology, focusing on clinical trials and evidence-based synthesis, at the Johns Hopkins Bloomberg School of Public Health. She joined the faculty of the division of pediatric infectious diseases in 2016.

Dr. Salazar-Austin’s research focuses on combining existing and new biomedical interventions in tuberculosis with novel pediatric health care delivery models to improve implementation of TB preventive therapy in TB-exposed children and adolescents with and without HIV worldwide.

Clinical Trials Summary

01/01/2020 - 08/30/2022

CHIP-TB Trial (Child Home Initiated Preventive treatment for TB)

Funded by UNITAID and the IMPAACT4TB project, this cluster-randomized trial will compare home-based vs clinic-based evaluation and initiation of TB preventive therapy (3RH or 3HP) in child TB contacts less than 15 years of age in Ethiopia and South Africa. This includes pre and post-trial qualitative assessments and a cost-effectiveness evaluation.

Principle Investigator 

07/01/2019-06/30/2022

Phase I/II Dose Finding, Safety and Tolerability Study of Daily Rifapentine Combined with Isoniazid (1HP) for Tuberculosis Prevention in Infants, Children and Adolescents

IMPAACT 2024 will study the PK and safety of 1HP, or one month of weekly rifapentine and isoniazid for TB prevention. This study will also assess drug interactions with dolutegravir and efavirenz in children living with HIV.

Co-chair

Selected Publications

  • Nicole Salazar-Austin, Jennifer Hoffmann, Silvia Cohn, Fildah Mashabela, Ziyaad Waja, Sanjay Lala, Christopher Hoffmann, Kelly E Dooley, Richard E Chaisson, Neil Martinson, TSHEPISO Study Team Poor Obstetric and Infant Outcomes in Human Immunodeficiency Virus-Infected Pregnant Women With Tuberculosis in South Africa: The Tshepiso Study, Clinical Infectious Diseases Volume 66, Issue 6, 15 March 2018, Pages 921–929

  • Nicole Salazar-Austin, Silvia Cohn, Grace Link Barnes, Molefi Tladi, Katlego Motlhaoleng, Catharina Swanepoel, Zarina Motala, Ebrahim Variava, Neil Martinson, Richard E Chaisson. Improving Tuberculosis Preventive Therapy Uptake: A Cluster-randomized Trial of Symptom-based Versus Tuberculin Skin Test-based Screening of Household Tuberculosis Contacts Less Than 5 Years of Age, Clinical Infectious Diseases Volume 70, Issue 8, 15 April 2020, Pages 1725–1732

  • Nicole Salazar-Austin, Silvia Cohn, Sanjay Lala, Ziyaad Waja, Kelly E Dooley, Christopher J Hoffmann, Richard E Chaisson, Neil Martinson and the TSHEPISO Study Team. Isoniazid Preventive Therapy and Pregnancy Outcomes In HIV-Infected Women in the Tshepiso Cohort, Clinical Infectious Diseases

Locations

  1. Rubenstein Child Health Building
    • 200 North Wolfe Street, Rubenstein BLDG Lower Level, Baltimore, MD 21287

    Expertise

    Education

    Johns Hopkins Bloomberg School of Public Health

    Graduate School, ScM, 2019

    Johns Hopkins University School of Medicine

    Fellowship, Pediatric Infectious Diseases, 2016

    Children's Hospital of Philadelphia

    Residency, Pediatrics, 2011

    Harvard Medical School

    Medical Education, MD, 2008

    Board Certifications

    Pediatric Infectious Diseases

    American Board of Pediatrics, 2017

    Pediatrics

    American Board of Pediatrics, 2011

    Insurance

    Johns Hopkins providers accept various commercial health insurance plans. However, they may not be included in all of an insurance company's plans or offerings. This may include Exchange, Medicaid, Medicare, and specific limited benefit plans. Exceptions to participation also exist based on your employer’s benefits package and the provider's location or specialty. Please contact your insurer directly to make sure your doctor is covered by your plan. For more details, please review our Insurance Information.
    Search plans
    • Aetna
    • CareFirst
    • Cigna
    • First Health
    • Geisinger Health Plan
    • HealthSmart/Accel
    • Humana
    • Johns Hopkins Health Plans
    • MultiPlan
    • Pennsylvania's Preferred Health Networks (PPHN)
    • Point Comfort Underwriters
    • Private Healthcare Systems (PHCS)
    • UnitedHealthcare
    • Veteran Affairs Community Care Network (Optum-VACCN)